|
COMMERCE BUSINESS DAILY ISSUE OF APRIL 16,1997 PSA#1825DEVELOPMENTS AT NIST Researchers at the National Institute of Standards
and Technology (NIST) have developed a number of new devices and
methods involving a variety of technologies. In certain cases other
parties have participated in the development of these technologies.
Anyone interested in the further development of any of these
technologies or in applying for a license to commercialize these
technologies should send a written request for further information,
referencing the NIST Docket Number and Title, to: National Institute of
Standards and Technology, Industrial Partnerships Program, Building
820, Room 213, Gaithersburg, Maryland 20899; Telecopy: 301-869-2751.
This is not an announcement of a contract action or a grant. NIST
DOCKET NUMBER: 96-045PA Title: Electroenzymatic Reactor For
Biocatalytic Hydroxylation Description: Interest in biocatalytic
hydroxylation derives from its ability to transform organic substrates
having no functional groups into oxygen-bearing compounds with high
regio-or stereo-selectivity. Use of redox enzymes in these syntheses is
hampered by intrinsic dependence on stoichiometric amounts of freely
dissociated cofactors, such as NADH and/or redox partner proteins,
which supply necessary reducing equivalents. Economic feasibility
requires that simple, effective and stable methods for cofactor
recycling be found. Electrochemical cofactor regeneration can meet
these requirements. Previously, a bioelectrochemical process has been
described in which electrons are transferred directly (without
mediators) between an electrode and redox-active biological material,
such as an enzyme or protein. In that work, electron transfer was
achieved using various modified metal or graphite electrodes. Such
processes suffer from either inefficiency (low redox reaction rates) or
rapid decline in activity due to component fouling by proteins. In the
present disclosure, the P450 enzymatic cycle, which requires a
continuous supply of reducing equivalents, molecular oxygen and an
amenable organic substrate, is utilized in an unique electroenzymatic
reactor to catalyze the generation of sterochemical hydroxylation
products. The reactor permits rapid and persistent electron transfer to
a P450 protein cofactor (putidaredoxin) by using certain tin oxide or
iridium oxide cathodes, while simultaneously providing necessary
dissolved oxygen at platinum or ruthenium oxide counter electrodes. The
need for NADH and the redox protein, flavin reductase, which are
required in the native cycle, has been eliminated. NIST DOCKET NUMBER:
97-016PA Title: Process For Enhanced Atomization, Vaporization And
Combustion Of Liquid Fuels Using Oxygen-Enriched Atomization Air
Description: A process, herein referred to as the 'MARNIOX' process, is
described in which control of composition of the atomization gas in
twin-fluid atomizers is used to enhance atomization, vaporization and
combustion of liquid fuels. The potential benefits associated with this
process include improved flame stability, combustion efficiency and
intensity, and reduced harmful pollutants to the environment. WEB: NIST
Contracts Homepage, http://www.nist.gov/admin/od/contract/contract.htm.
E-MAIL: NIST Contracts Office, Contract@nist.gov. Loren Data Corp. http://www.ld.com (SYN# 0428 19970416\SP-0006.MSC)
SP - Special Notices Index Page
|
|